Actoxumab
id:
actoxumab-190-18198415
title:
Actoxumab
text:
Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection. This drug, along with bezlotoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School. The project was then licensed to Merck & Co., Inc. for further development and commercialization. A study compared it with bezlotoxumab and found Actoxumab less effective.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Actoxumab
date created:
date modified:
2023-12-01T20:34:17Z
main entity:
{"identifier":"Q4677750","url":"https://www.wikidata.org/entity/Q4677750"}
image:
fields total:
13
integrity:
14